Lexaria Bioscience LEXX
NASDAQ LEXX
$2.88 -0.21 (-6.80%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lexaria Bioscience (LEXX) Cash & Current Investments (2010 - 2026)

Updated

Lexaria Bioscience's Cash & Current Investments came in at $3.62 million for fiscal Q3 2026 (quarter ended May 31, 2026), down 21.8% from $4.63 million a year earlier and down 31.4% from the prior quarter.

Analysis

Lexaria Bioscience (LEXX) Cash & Current Investments (2010 - 2026) Analysis & Trends

At the end of FY2025 (ended Aug 31, 2025), Lexaria Bioscience's Cash & Current Investments was $1.95 million, down 70.3% from FY2024.

  • Cash & Current Investments carries a five-year compound annual growth rate of 8.2% (FY2020 to FY2025).
  • Going back by fiscal year, Cash & Current Investments was $6.56 million in FY2024 (+343.6%), $1.48 million in FY2023 (-76.0%), $6.16 million in FY2022 (-47.6%) and $11.75 million in FY2021 (+795.0%).
  • The five-year range for quarterly Cash & Current Investments is $1.48 million (fiscal Q4 2023) to $11.75 million (fiscal Q4 2021).
  • Year-over-year, Cash & Current Investments has declined for five consecutive quarters, with growth averaging 59.8% over the last eight quarters.
  • The fastest year-over-year change in Cash & Current Investments over five years came in fiscal Q4 2021 (growth of 795.0%), and the weakest in fiscal Q4 2023 (a decline of 76.0%).
  • Business Quant data shows LEXX's Cash & Current Investments at $5.27 million (Q2 2026), $4.42 million (Q1 2026) and $1.95 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Lexaria Bioscience 3.04 Mn -12.61 Mn - 3.62 Mn
Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 3.62 Mn
Feb 28, 2026 5.27 Mn
Nov 30, 2025 4.42 Mn
Aug 31, 2025 1.95 Mn
May 31, 2025 4.63 Mn
Feb 28, 2025 6.54 Mn
Nov 30, 2024 8.12 Mn
Aug 31, 2024 6.56 Mn
May 31, 2024 8.51 Mn
Feb 29, 2024 4.79 Mn
Nov 30, 2023 2.03 Mn
Aug 31, 2023 1.48 Mn
May 31, 2023 3.43 Mn
Feb 28, 2023 3.54 Mn
Nov 30, 2022 4.80 Mn
Aug 31, 2022 6.16 Mn
May 31, 2022 7.34 Mn
Feb 28, 2022 8.91 Mn
Nov 30, 2021 10.18 Mn
Aug 31, 2021 11.75 Mn
API Access

Lexaria Bioscience Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=LEXX&period=max&api_key=YOUR_API_KEY